Rafferty Asset Management, LLC Enochian Biosciences Inc Transaction History

Rafferty Asset Management, LLC

  • $28.9 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$1.7 - $2.86 $1,725 - $2,902
1,015 Added 4.02%
26,273 $48,000
Q2 2022

Aug 12, 2022
BUY
$1.93 - $8.73 $16,767 - $75,846
8,688 Added 52.43%
25,258 $49,000
Q1 2022

May 13, 2022
BUY
$4.42 - $9.0 $73,239 - $149,130
16,570 New
16,570 $137,000

Others Institutions Holding ENOB

# of Institutions
51
Shares Held
14.7M
Call Options Held
24K
Put Options Held
19.1K
View Full List

About Enochian Biosciences Inc

ENOB Quotes by TradingView
  • Ticker ENOB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,950,000
  • Market Cap $244M
  • Description
  • Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...
More about ENOB
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email